INDV
INDV
NASDAQ · Pharmaceuticals

Indivior Pharmaceuticals Inc

$39.50
-0.10 (-0.25%)
As of May 9, 1:20 AM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +22.8% upside
Low Target $40.68
Average Target $48.50
High Target $71.11
Current Price $39.50
Current
$39.50
Target
$48.50
$40.68 $48.50 avg $71.11
Scenario Analysis
Bear Case
$40.68
3.0%
Low target
Base Case
$48.50
+22.8%
Avg target
Bull Case
$71.11
+80.0%
High target
Risk/Reward
26.8x
Highly favorable
Price in Context
52-Week High
$41.00
-3.7% from high
52-Week Low
$10.63
+271.6% from low
50-Day SMA
$34.90
+13.2% vs SMA
200-Day SMA
$24.61
+60.5% vs SMA
RSI (14)
47.8
Neutral
Target vs 52W High
$48.50
+18.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 69% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 35 43% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%